The PE Ratio as of November 2024 (TTM) for Pieris Pharmaceuticals, Inc. (PIRS) is -1.39

According to Pieris Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.39. This represents a change of 18.28% compared to the average of -1.18 of the last 4 quarters.

Pieris Pharmaceuticals, Inc. (PIRS) Historical PE Ratio (quarterly & annually)

How has PIRS PE Ratio performed in the past?

The mean historical PE Ratio of Pieris Pharmaceuticals, Inc. over the last ten years is -6.31. The current -1.39 PE Ratio has changed 2.10% with respect to the historical average. Over the past ten years (40 quarters), PIRS's PE Ratio was at its highest in in the December 2017 quarter at 11.30. The PE Ratio was at its lowest in in the June 2018 quarter at -337.06.

Pieris Pharmaceuticals, Inc. (PIRS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Pieris Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pieris Pharmaceuticals, Inc. (PIRS) Average PE Ratio

How has PIRS PE Ratio performed in the past?

The current PE Ratio of Pieris Pharmaceuticals, Inc. (PIRS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Pieris Pharmaceuticals, Inc. (PIRS) PE Ratio vs. Peers

How is PIRS’s PE Ratio compared to its peers?

Pieris Pharmaceuticals, Inc.’s PE Ratio is greater than Adaptimmune Therapeutics plc (-3.77), greater than Mereo BioPharma Group plc (-13.56), greater than PDS Biotechnology Corporation (-1.90), greater than Leap Therapeutics, Inc. (-1.63), greater than X4 Pharmaceuticals, Inc. (-4.05), greater than Corvus Pharmaceuticals, Inc. (-10.50), greater than Terns Pharmaceuticals, Inc. (-5.12), less than TCR2 Therapeutics Inc. (-0.38), less than Affimed N.V. (-0.54), less than ADC Therapeutics SA (-0.98), less than Agenus Inc. (-0.32), greater than Inozyme Pharma, Inc. (-1.84), less than Achilles Therapeutics plc (-0.64), greater than Checkpoint Therapeutics, Inc. (-3.48), less than Cue Biopharma, Inc. (-1.17), greater than Medicenna Therapeutics Corp. (-2.32),

Build a custom stock screener for Pieris Pharmaceuticals, Inc. (PIRS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pieris Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pieris Pharmaceuticals, Inc. (PIRS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pieris Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.